THE CLINICAL-VALUE OF INTERFERONS AS ANTI-TUMOR AGENTS

被引：60

作者：

BILLIAU, A

机构：

来源：

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 1981年 / 17卷 / 09期

关键词：

D O I：

10.1016/S0014-2964(81)80001-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：949 / 967

页数：19

相关论文

共 130 条

[1] SENSITIVITY OF EPSTEIN-BARR VIRUS TRANSFORMED HUMAN LYMPHOID-CELL LINES TO INTERFERON
ADAMS, A
STRANDER, H
CANTELL, K
[J]. JOURNAL OF GENERAL VIROLOGY, 1975, 28 (AUG) : 207 - 217
[2] ATALLAH AM, 1979, INT ARCH ALLERGY, V60, P377
[3] HUMAN-LYMPHOBLASTOID INTERFERON CAN INHIBIT THE GROWTH OF HUMAN-BREAST CANCER XENOGRAFTS IN ATHYMIC (NUDE) MICE
BALKWILL, F
TAYLORPAPADIMITRIOU, J
FANTES, KH
SEBESTENY, A
[J]. EUROPEAN JOURNAL OF CANCER, 1980, 16 (04) : 569 - 573
[4] BERGERET M, 1980, IMMUNOLOGY, V40, P637
[5] INTERFERON THERAPY IN MULTIPLE-MYELOMA - FAILURE OF HUMAN FIBROBLAST INTERFERON ADMINISTRATION TO AFFECT THE COURSE OF LIGHT CHAIN DISEASE
BILLIAU, A
BLOEMMEN, J
BOGAERTS, M
CLAEYS, H
VANDAMME, J
DELEY, M
DESOMER, P
DROCHMANS, A
HEREMANS, H
KRIEL, A
SCHETZ, J
TRICOT, G
VERMYLEN, C
VERWILGHEN, R
WAER, M
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1981, 17 (08): : 875 - 882
[6] HUMAN FIBROBLAST INTERFERON FOR CLINICAL-TRIALS - PRODUCTION, PARTIAL-PURIFICATION, AND CHARACTERIZATION
BILLIAU, A
VANDAMME, J
VANLEUVEN, F
EDY, VG
DELEY, M
CASSIMAN, JJ
VANDENBERGHE, H
DESOMER, P
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (01) : 49 - 55
[7] INTERFERON THERAPY - PHARMACOKINETIC AND PHARMACOLOGICAL ASPECTS - BRIEF REVIEW
BILLIAU, A
[J]. ARCHIVES OF VIROLOGY, 1981, 67 (02) : 121 - 133
[8] HUMAN FIBROBLAST INTERFERON FOR CLINICAL-TRIALS - PHARMACOKINETICS AND TOLERABILITY IN EXPERIMENTAL-ANIMALS AND HUMANS
BILLIAU, A
DESOMER, P
EDY, VG
DECLERCQ, E
HEREMANS, H
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 16 (01) : 56 - 63
[9] BLOMGREN H, 1976, ACTA MED SCAND, V199, P527
[10] BORDEN EC, 1981, 1980 P C CLIN POT IN

← 1 2 3 4 5 6 7 8 9 10 →